Definium Therapeutics, Inc.·4

Jun 15, 4:30 PM ET

GRYSKA DAVID W 4

4 · Definium Therapeutics, Inc. · Filed Jun 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Definium (DFTX) Director David Gryska Receives RSU & Option Grant

What Happened David W. Gryska, a member of the board of directors of Definium Therapeutics, was awarded two equity grants on June 11, 2026: 4,666 restricted stock units (RSUs) and a 19,188-share derivative award (stock option). Both awards were reported as grants at $0.00 per share (no cash paid at grant). These are awards/compensation grants (code A), not open-market purchases or sales.

Key Details

  • Transaction date: 2026-06-11; Form 4 filed 2026-06-15 (filed within required two business days).
  • Consideration: both grants reported at $0.00 (no cash paid at grant).
  • Vesting: RSUs and the stock option vest 1/12th on each monthly anniversary of the grant date; if the company’s next annual meeting occurs before the first anniversary, any unvested awards will vest immediately prior to that meeting, subject to continued service (see footnotes F1 and F2).
  • Shares owned following the transaction: not disclosed in the provided filing excerpt.
  • Nature of transaction: award/grant (compensation), not an exercise-and-sale or market trade.

Context These grants are routine director/executive compensation and are contingent on continued service and the stated vesting schedule. The 19,188-share entry is a derivative (stock option) award that vests monthly per the footnote; it was granted, not exercised, so no immediate share sale or cashless exercise occurred. Awards reported at $0 are common for equity compensation and do not by themselves indicate buying or selling intent.

Insider Transaction Report

Form 4
Period: 2026-06-11
Transactions
  • Award

    Common Shares

    [F1]
    2026-06-11+4,66619,900 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-06-11+19,18819,188 total
    Exercise: $24.11Exp: 2036-06-10Common Shares (19,188 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
  • [F2]The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Signature
/s/ Mark Sullivan, Attorney-in-Fact for David W Gryska|2026-06-15

Documents

2 files